Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6712
Gene Symbol: SPTBN2
SPTBN2
0.100 GeneticVariation disease CLINVAR
Entrez Id: 80025
Gene Symbol: PANK2
PANK2
0.100 CausalMutation disease CLINVAR
Entrez Id: 1385
Gene Symbol: CREB1
CREB1
0.020 AlteredExpression disease BEFREE Although this mechanism underlying the beneficial effect of Riluzole on AIMs needs to be confirmed, it provides clues towards novel or existing compounds for the treatment of AIMs that modulate the activity of CREB1 and, hence, its downstream targets. 30484112 2019
Entrez Id: 1385
Gene Symbol: CREB1
CREB1
0.020 Biomarker disease BEFREE In addition, the antidyskinetic effects of KD5040 on pathological movements triggered by <sub>l</sub> -dopa were investigated by testing abnormal involuntary movements (AIMs) and measuring the activations of FosB, cAMP-dependent phosphor protein of 32 kDa (DARPP-32), extracellular signal-regulated kinases (ERK), and cAMP response element-binding (CREB) protein in the striatum. 28424060 2017
Entrez Id: 1565
Gene Symbol: CYP2D6
CYP2D6
0.020 GeneticVariation disease BEFREE In patients tested for CYP2D6, an association between genotype and tardive dyskinesia (including Abnormal Involuntary Movement Scale scores) was found. 20031087 2010
Entrez Id: 1565
Gene Symbol: CYP2D6
CYP2D6
0.020 GeneticVariation disease BEFREE In the present study, we examined the relationship between the CYP2D6*10 C188T polymorphism and the TD occurrence in 216 Chinese schizophrenic patients (113 patients with TD and 103 patients without TD) and explored the correlation between the TD severity assessed by the Abnormal Involuntary Movement Scale (AIMS) and each C188T genotype in the 113 TD patients. 15118351 2004
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
0.020 GeneticVariation disease BEFREE Interactive effect of cytochrome P450 17alpha-hydroxylase and dopamine D3 receptor gene polymorphisms on abnormal involuntary movements in chronic schizophrenia. 11839369 2002
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
0.020 GeneticVariation disease BEFREE DRD3 genotype and age at first antipsychotic treatment contributed significantly to total score on the Abnormal Involuntary Movements Scale (AIMS). 10395214 1999
Entrez Id: 54112
Gene Symbol: GPR88
GPR88
0.010 Biomarker disease BEFREE Conversely, GPR88 KO mice had a lower abnormal involuntary movements (AIMs) score. 31666199 2020
Entrez Id: 2010
Gene Symbol: EMD
EMD
0.010 Biomarker disease BEFREE Dyskinetic 6-OHDA-lesioned rats were then administered EMD-281,014 (0.01, 0.03 and 0.1 mg/kg) or vehicle in combination with L-DOPA and AIMs severity was evaluated. 30298296 2019
Entrez Id: 2066
Gene Symbol: ERBB4
ERBB4
0.010 GeneticVariation disease BEFREE We found the ERBB4 rs839523 CC genotype to be associated with risk for TD occurrence and increased severity as measured by the Abnormal Involuntary Movement Scale (AIMS) (P = .003). 28394697 2019
Entrez Id: 5309
Gene Symbol: PITX3
PITX3
0.010 Biomarker disease BEFREE Acupuncture stimulation at GB34 alleviated abnormal involuntary movements (AIMs) in Pitx3-deficient aphakia mice (ak/ak) following L-DOPA administration and these effects were reproduced in 6-hydroxydopamine (6-OHDA)-lesioned mice with LID. 30030752 2019
Entrez Id: 3350
Gene Symbol: HTR1A
HTR1A
0.010 Biomarker disease BEFREE The aims of this study were firstly to investigate oscillations in main BG input and output structures-the dorsolateral striatum (dStr) and substantia nigra pars reticulata (SNr), respectively- including the direction of oscillation information flow, and secondly to investigate the effects of 5-HT1A/B receptor agonism with eltoprazine on oscillatory activities and abnormal involuntary movements (AIMs) characteristic. 30612008 2019
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.010 AlteredExpression disease BEFREE Correlation between dopamine receptor D2 expression and presence of abnormal involuntary movements in Wistar rats with hemiparkinsonism and dyskinesia. 29525397 2018
Entrez Id: 84152
Gene Symbol: PPP1R1B
PPP1R1B
0.010 Biomarker disease BEFREE In addition, the antidyskinetic effects of KD5040 on pathological movements triggered by <sub>l</sub> -dopa were investigated by testing abnormal involuntary movements (AIMs) and measuring the activations of FosB, cAMP-dependent phosphor protein of 32 kDa (DARPP-32), extracellular signal-regulated kinases (ERK), and cAMP response element-binding (CREB) protein in the striatum. 28424060 2017
Entrez Id: 2571
Gene Symbol: GAD1
GAD1
0.010 Biomarker disease BEFREE Abnormal involuntary movements (AIMs) were evaluated on days 3, 8, 13, and 18 after l-DOPA administration, and real-time polymerase chain reaction and immunohistochemistry for glutamic acid decarboxylase (GAD) 65 and GAD67 were performed. 28377741 2017
Entrez Id: 2290
Gene Symbol: FOXG1
FOXG1
0.010 GeneticVariation disease BEFREE Abnormal involuntary movements are a major feature of FOXG1 mutations. 27029630 2016
Entrez Id: 3164
Gene Symbol: NR4A1
NR4A1
0.010 GeneticVariation disease BEFREE The NR4A1 single nucleotide polymorphism (SNP) marker rs2603751 showed a nominal association with the risk of TD, as well as with the extent of TD based on the Abnormal Involuntary Movements Scale (AIMS) scores. 20010315 2010
Entrez Id: 6648
Gene Symbol: SOD2
SOD2
0.010 GeneticVariation disease BEFREE This study examined whether the manganese superoxide dismutase (MnSOD) gene Ala-9Val single-nucleotide polymorphism (SNP) is associated with neuroleptic-induced tardive dyskinesia (TD) and the severity of the abnormal involuntary movements in Korean schizophrenic patients. 18790709 2008
Entrez Id: 8787
Gene Symbol: RGS9
RGS9
0.010 Biomarker disease BEFREE We report that RGS9 knock-out mice develop abnormal involuntary movements when inhibition of dopaminergic transmission is followed by activation of D2-like dopamine receptors (DRs). 15728856 2005
Entrez Id: 4128
Gene Symbol: MAOA
MAOA
0.010 GeneticVariation disease BEFREE No significant difference was found in total scores on the Abnormal Involuntary Movement Scale (AIMS) among the subject groups, sorted according to the COMT, MAOA and MAOB genotypes. 15261699 2004
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.010 GeneticVariation disease BEFREE No significant difference was found in total scores on the Abnormal Involuntary Movement Scale (AIMS) among the subject groups, sorted according to the COMT, MAOA and MAOB genotypes. 15261699 2004
Entrez Id: 4129
Gene Symbol: MAOB
MAOB
0.010 GeneticVariation disease BEFREE No significant difference was found in total scores on the Abnormal Involuntary Movement Scale (AIMS) among the subject groups, sorted according to the COMT, MAOA and MAOB genotypes. 15261699 2004
Entrez Id: 7167
Gene Symbol: TPI1
TPI1
0.010 Biomarker disease BEFREE A patient with triosephosphate isomerase (TPI) deficiency exhibited worsening of abnormal involuntary movements of the dystonic type and developed psychiatric symptoms while on selegiline. 14743370 2004
Entrez Id: 4051
Gene Symbol: CYP4F3
CYP4F3
0.010 GeneticVariation disease BEFREE Interactive effects of cytochrome P 450 17alpha-hydroxylase with the dopamine D3 Ser9Gly polymorphism on abnormal involuntary movements were examined. 11839369 2002